Start Date
September 30, 2017
Primary Completion Date
November 30, 2017
Study Completion Date
November 30, 2017
Norco 5Mg-325Mg Tablet
Single oral dose in one of the four cross-over trial periods.
GRT7014 - Abuse Deterrent Tablet
Single oral dose in one of the four cross-over trial periods.
US001: PRA Health Sciences, Lenexa
Lead Sponsor
Grünenthal GmbH
INDUSTRY